Pfizer Targets Apotex In Fight To Block Generic Lyrica

Law360, New York (July 11, 2011, 2:10 PM EDT) -- Pfizer Inc. sued Apotex Inc. in Delaware federal court on Friday in an effort to block the Canadian generics maker from marketing its own version of blockbuster nerve pain drug Lyrica.

Pfizer claims Toronto-based Apotex, Canada's largest pharmaceutical company, has infringed two patents with its plans to manufacture an alternative to Lyrica, which is available in capsule and oral solution form. Pfizer “will be substantially and irreparably harmed if Apotex is not enjoined from infringing,” the suit said.

A representative for Apotex did not immediately return...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.